Testing effectiveness (Phase 2)Ended earlyNCT02905981
What this trial is testing
Triferic IRIDA (Iron-Refractory Iron-Deficiency Anemia) Protocol
Who this might be right for
Iron-Refractory Iron-Deficiency Anemia
Rockwell Medical Technologies, Inc. 1